Generex adds Emmaus CEO to board | S&P Global Market Intelligence

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Unlocking Insights Across the Supply Chain
- 05/11/2022
- On-Demand
- 1 Hour
Conference10th Annual Community Bankers Conference
- 05/16/2022
- Four Seasons Resort and Club, Dallas at Las Colinas
- Dallas, Texas
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

Generex adds Emmaus CEO to board

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Global M&A By the Numbers: Q1 2022

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Investment Banking Essentials Newsletter April Edition - 2022

25 Jan, 2017 | 23:15

Generex adds Emmaus CEO to board

Author Angelee Tabios
Theme Healthcare & Pharmaceuticals

Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.

Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.